ProPhase Labs, Inc. — Director's Dealing 2022

May 25, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2022-05-23

Reporting Person: Karkus Ted William (Director, CEO & CHAIRMAN, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-23	Common Stock, par value $0.005	M	450000	$2.00	Acquired	2783471	Direct
2022-05-23	Common Stock, par value $0.005	F	278257	$8.47	Disposed	2505214	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-23	Option (right to buy)	$2.00	M	450000	Disposed	2024-04-27	Common Stock (450000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.005	100000	Indirect

Footnotes

F1: On May 23, 2022, the Reporting Person acquired net 171,743 shares of common stock upon the exercise of stock options to purchase 450,000 shares of common stock, less 278,257 shares of common stock withheld to cover the exercise price and applicable taxes.

F2: The option vested in four equal annual installments beginning April 26, 2018, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of April 27, 2017.